New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA Approves Three New Rapid At-Home COVID Tests

The Agency hopes the increased availability of rapid tests can help slow the spread of the pandemic.

A recent article from The New York Times noted the United States’ increase in rapid testing for COVID-19. Amid record high cases of the virus, U.S. testing officials announced a scale-up in diagnostic testing last week. The government will pump $550 million into community-based testing in all 50 states, and allocate another $300 million to provide nursing homes and other vulnerable communities with 60 million test kits.

According to Dr. Giroir, the country’s non-laboratory testing could more than double by mid-year. To make this happen, the FDA just granted emergency approval to three new at-home testing kits from Ellume, Abbott, and Lucira Health. All three tests deliver results in just a few minutes with a nasal swab, but only the Ellume test can be purchased without a prescription. 

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub